| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |